Prologis Invests £500 Million in Cambridge Campus

Prologis, a San Francisco-based developer, has announced a £500 million investment to expand the Cambridge Biomedical Campus, a move hailed by Chancellor Rachel Reeves as a significant endorsement of the UK government's economic strategy. The expansion, covering 115,000 square feet, is expected to create over 2,120 highly-skilled jobs and contribute millions annually to the UK economy, which already benefits from the campus generating £4.2 billion each year. This investment comes shortly after the Chancellor's first budget aimed at stimulating private sector investment. Ms. Reeves emphasized the importance of this funding in enhancing the UK's life sciences sector and improving access to innovative healthcare solutions. Prologis has committed to the UK for over 20 years and views this development as critical infrastructure for economic growth. The Cambridge Biomedical Campus plays a vital role in addressing global healthcare challenges, including early cancer detection and dementia research.